Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24 ‐month Clinical Study

ConclusionsThese data show that early application of zoledronic acid 5 mg/year was well stimulated and tolerated for bone mass in newly diagnosed east china subjects with osteoporosis in a 24‐month treatment.

Source: Orthopaedic Surgery - March 9, 2017 Category: Orthopaedics Authors: Bo ‐cheng Liang, Zhen‐yu Shi, Bo Wang, Peng Wu, Ling‐cheng Kong, Jian‐liang Yao, Chun‐wen Li, Xiao‐lin Shi Tags: CLINICAL ARTICLE Source Type: research